Alan Weichselbaum
CIK: 0001435390
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Weichselbaum Alan
Weichselbaum Alan (SEC CIK 0001435390) files insider reports with the SEC as Director of Finwise Bancorp (FINW), Chief Financial Officer of Telomir Pharmaceuticals, Inc. (TELO) and Chief Financial Officer of MIRA PHARMACEUTICALS, INC. (MIRA).
Signal8 holds 4 ownership filings by Weichselbaum Alan (2 Form 3, 2 Form 4), filed between May 29, 2025 and Apr 1, 2026. Those filings report 2 transactions, from May 27, 2025 to Mar 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Weichselbaum Alan's filings is in MURRAY, UT.
Recent filings by Weichselbaum Alan
Other insiders filing for Finwise Bancorp (FINW)
- Noone James, CHIEF EXECUTIVE OFFICER
- Wahlman Robert E., EVP, Chief Financial Officer
- OBrien Michael Christopher
- Thiessens Richard, Officer
- Landvatter Kent, EXECUTIVE CHAIRMAN
- Clayton Natasha Laurette